INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 36 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $105,000 | -68.8% | 144,414 | +86.7% | 0.00% | -75.0% |
| Q2 2019 | $336,000 | -17.8% | 77,348 | +38.5% | 0.01% | -33.3% |
| Q1 2019 | $409,000 | -43.7% | 55,838 | -42.1% | 0.01% | -60.0% |
| Q4 2018 | $727,000 | +19.4% | 96,370 | -10.6% | 0.03% | +66.7% |
| Q3 2018 | $609,000 | – | 107,761 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |